Goal2Quit + NRT Sampling for Depression

N/A

Waitlist Available

Led By Jennifer Dahne, PhD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from 7 days preceding the 12-week follow-up assessment through the 12-week follow-up assessment.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a new way to help people with depression quit smoking. It combines a mobile app that uses mood-boosting activities with samples of nicotine patches or gum. The goal is to make it easier for people with depression to stop smoking.

Eligible Conditions

Depression
Smoking Cessation
Smoking/Cigarette Smoking

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from 7 days preceding the 12-week follow-up assessment through the 12-week follow-up assessment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from 7 days preceding the 12-week follow-up assessment through the 12-week follow-up assessment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from 7 days preceding the 12-week follow-up assessment through the 12-week follow-up assessment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

7 Day Point Prevalence Abstinence

Secondary study objectives

Mean Score of Depressive Symptoms

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Treatment As UsualExperimental Treatment1 Intervention

Participants in the Treatment As Usual condition will receive educational material on quitting smoking. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

Group II: Goal2Quit + NRT SamplingExperimental Treatment1 Intervention

Participants in the Goal2Quit + NRT Sampling condition will receive a download code to download the Goal2Quit mobile application. Goal2Quit is a mobile app for cigarette smokers with elevated symptoms of depression. Within the app, users identify values, create activities, schedule activities, rate mood daily, and track cigarette smoking. Participants in Group B will also receive a two-week "starter kit" sample of nicotine replacement therapy (NRT; 14mg patch and 4mg lozenge). Participants will be asked to utilize Goal2Quit regularly, at least once per day, as well as the NRT sample in an attempt to quit smoking. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Goal2Quit + NRT Sampling

2020

N/A

~170

Treatment as Usual

2016

Completed Phase 3

~2710